HomeOwner SearchCategory Search
Visit USCOTherapeutic Advances in Relapsed/Refractory DLBCL: A Focus on Emerging Agents
Motion Picture Registration
Copyright Title
Therapeutic Advances in Relapsed/Refractory DLBCL: A Focus on Emerging Agents
Status
Published
on 7 Feb 2020
Year of Creation
2020
Copyright Claimant
Med-IQ
Registration Number
PA0002235629
on 7 Feb 2020Copyright Summary
The U.S. Copyright record (Registration Number: PA0002235629) dated 7 Feb 2020, pertains to an electronic file (eService) titled "Therapeutic Advances in Relapsed/Refractory DLBCL: A Focus on Emerging Agents " created in 2020. The copyright holder is Med-IQ, known for their creative contributions in motion picture registration. For any inquiries concerning this copyrighted material, kindly reach out to Med-IQ.
Application Details
Registration Number
PA0002235629
Registration Date
2/7/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Med-IQ
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Susan Dembeck, Med-IQ, 5523 Research Park Dr, Ste 210, Baltimore, MD, 21228, United States, (443) 543-5114, sdembeck@med-iq.com
Statements
Application Title Statement: Therapeutic Advances in Relapsed/Refractory DLBCL: A Focus on Emerging Agents
Author Statement: Med-IQ employer for hire Citizenship: United States Authorship: entire motion picture
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.